Brief: Egetis Receives Positive Opinion From European Medicines Agency
13/07/2022 07:09
July 13 (Reuters) - Egetis Therapeutics AB (publ) EGTX.ST :
* RECEIVES POSITIVE OPINION ON ORPHAN DESIGNATION FOR
ALADOTE FROM
THE EUROPEAN MEDICINES AGENCY FOR THE PREVENTION OF ACUTE LIVER
FAILURE
Source text for Eikon: ID:nMFN8kXNbY
Further company coverage: EGTX.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))